Natural Capsules Ltd

Natural Capsules Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.152 today, marking a significant decline in its stock price amid ongoing challenges and sector dynamics.

Natural Capsules Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Natural Capsules Ltd has touched a new 52-week low of Rs.155.65 today, marking a significant decline in its stock price amid ongoing challenges reflected in its financial performance and market positioning.

Natural Capsules Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.155.65 today, marking a significant decline amid ongoing downward momentum. The stock’s performance continues to trail its sector and benchmark indices, reflecting persistent pressures on its valuation and financial metrics.

Natural Capsules Ltd touched a new 52-week low of Rs.160.45 today, marking a significant decline in its stock price amid ongoing challenges in its financial performance and market positioning. The stock’s fall comes despite an initial gap-up opening and intraday volatility, reflecting persistent pressures within the Pharmaceuticals & Biotechnology sector.

Natural Capsules Ltd, a player in the Pharmaceuticals & Biotechnology sector, has declined to a fresh 52-week low of Rs.163, marking a significant downturn in its stock performance amid persistent financial headwinds and sector underperformance.

Natural Capsules Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 January 2026, providing investors with the latest insights into its performance and outlook.

Natural Capsules Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge on 2 Jan 2026, hitting its upper circuit limit with a maximum daily gain of 9.99%. This sharp rally was driven by strong buying interest, elevated investor participation, and a significant unfilled demand, signalling renewed optimism despite the company’s recent downgrade to a Strong Sell rating by MarketsMOJO.

Natural Capsules Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 25 December 2025, providing investors with the latest comprehensive view of the company’s position.

Natural Capsules, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical pattern where the 50-day moving average crosses below the 200-day moving average. This development often signals a shift towards a bearish trend and suggests a weakening momentum in the stock’s price action over the longer term.

Natural Capsules, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a notable revision in its market evaluation. This shift reflects recent developments across multiple analytical parameters, highlighting ongoing challenges in the company’s financial and operational performance.

Natural Capsules Ltd is currently experiencing extreme selling pressure, with only sell orders queued and no buyers visible in the market. This situation signals distress selling and highlights a challenging phase for the pharmaceutical company as it navigates a series of consecutive losses against broader market gains.

Natural Capsules Ltd has attracted remarkable buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market behaviour signals a potential multi-day circuit scenario, reflecting strong demand despite recent mixed performance metrics.

Natural Capsules Ltd witnessed a significant surge in its share price on 28 Nov 2025, hitting the upper circuit limit of 5%, closing at ₹185.72. This movement reflects robust buying interest and a maximum daily gain that outpaced its sector and benchmark indices, signalling heightened investor enthusiasm despite a micro-cap market capitalisation of ₹183 crore.

Natural Capsules Ltd has witnessed extraordinary buying momentum today, hitting the upper circuit with only buy orders in the queue. This rare market phenomenon highlights intense demand for the stock, with no sellers willing to part with shares, suggesting the possibility of a multi-day circuit scenario.

Natural Capsules Ltd has attracted extraordinary buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand and a complete absence of sellers.

Natural Capsules Ltd is currently experiencing significant selling pressure, with the stock registering consecutive declines and a complete absence of buyers today. This distress selling scenario highlights mounting concerns among investors as the pharmaceutical company underperforms relative to key market benchmarks.

Natural Capsules Ltd has attracted extraordinary buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, underscoring intense demand amid a lack of sellers.